The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.2 (OPD) Tungsten Corporation

22 Dec 2021 07:00

RNS Number : 4199W
Tungsten Corporation PLC
22 December 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Tungsten Corporation plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Tungsten Corporation plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

21 December 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests of directors of Tungsten Corporation plc in Tungsten Corporation plc

 

Director

Number of ordinary shares in Tungsten Corporation plc

Percentage of total issued share capital (%)

Tony Bromovsky (1)

934,104

0.74

Paul Cooper

19,500

0.00

Andrew Doman (2)

251,649

0.20

Nicholas Wells (3)

100,000

0.08

 

(1) Held through Forest Nominees Ltd.

(2) Held through Hargreaves Lansdown Nominees Ltd.

(3) Held through Smith and Williamson Nominees Ltd.

 

(b) Directors' rights to subscribe for Tungsten Corporation plc's shares under Tungsten Corporation plc's share plans

 

Award under Tungsten Corporation plc Deferred Share Bonus Plan

 

Director

Number of shares

Vesting date

Exercise price (pence)

Tony Bromovsky

376,166

 

50% vested on 30 October 2021 and 50% on will vest on 30 October 2022 (1)

 

0.438

 

(1) These options become exercisable on an offer to acquire the entire issued share capital of Tungsten Corporation plc being made unconditional in all respects, resulting in a change of control of Tungsten Corporation plc.

 

Long Term Incentive Plan

 

Director

Number of shares

Vesting period

Exercise price (pence)

Paul Cooper

160,467

20 August 2024 (1)

 

0.438

 

(1) These options become exercisable on an offer to acquire the entire issued share capital of Tungsten Corporation plc being made unconditional in all respects, resulting in a change of control of Tungsten Corporation plc.

 

(c) Interests of connected advisers of Tungsten Corporation plc in Tungsten Corporation plc's shares

 

Connected Adviser

Number of ordinary shares in Tungsten Corporation plc

Percentage of total issued share capital (%)

Canaccord Genuity LLC

5,000

0.00

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

22 December 2021

Contact name:

Paul Cooper

Telephone number:

Tel: +44 (0) 20 7280 6980

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEDKDBNBBDBABB
Date   Source Headline
15th Dec 20212:41 pmRNSStatement Re Possible Offer for Tungsten Corp
15th Dec 20212:35 pmEQSForm 8.3 - Maitland Institutional Services Limited: Form 8.3 (OPD) - Tungsten Corp Plc
15th Dec 20212:12 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Tungsten Corporation plc
15th Dec 20212:00 pmRNSForm 8.3 - Tungsten
15th Dec 20211:45 pmRNSForm 8.3
15th Dec 202112:13 pmBUSForm 8.3 - Tungsten Corporation plc
14th Dec 20215:35 pmRNSStatement re Possible Offer
14th Dec 20213:18 pmRNSStatement re Possible Offer
13th Dec 20217:01 amRNSInterim Results
13th Dec 20217:00 amRNSUS Litigation Settlement
7th Dec 20217:00 amRNSInvestor Presentation
3rd Dec 20217:00 amRNSPartnership Agreement
1st Dec 202111:27 amRNSHolding(s) in Company
30th Nov 202111:15 amRNSHolding(s) in Company
29th Nov 20214:41 pmRNSSecond Price Monitoring Extn
29th Nov 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSHolding(s) in Company
25th Nov 20217:00 amRNSHolding(s) in Company
23rd Nov 20213:02 pmRNSHolding(s) in Company
22nd Nov 20215:44 pmRNSHolding(s) in Company
22nd Nov 20217:00 amRNSHolding(s) in Company
4th Nov 20214:36 pmRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSCustomer Win
2nd Nov 20217:10 amRNSCustomer Contract Cancellation
15th Oct 20213:28 pmRNSResult of AGM
14th Oct 20214:36 pmRNSHolding(s) in Company
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
7th Oct 20214:41 pmRNSSecond Price Monitoring Extn
7th Oct 20214:36 pmRNSPrice Monitoring Extension
30th Sep 20217:07 amRNSISAE 3402 Accreditation
23rd Sep 20217:00 amRNSPosting of Report and Accounts and Notice of AGM
16th Sep 20215:03 pmRNSDirector Appointment
16th Sep 20218:40 amRNSSupply Chain Finance Partnership
27th Aug 20217:00 amRNSAdditional Listing and Total Voting Rights
23rd Aug 20217:00 amRNSDirector/PDMR Shareholdings
30th Jul 20217:00 amRNSFinal Results
15th Jun 20214:40 pmRNSSecond Price Monitoring Extn
15th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20217:00 amRNSDirectorate Change
10th Jun 20214:40 pmRNSSecond Price Monitoring Extn
10th Jun 20214:35 pmRNSPrice Monitoring Extension
9th Jun 20217:00 amRNSChange of Chief Executive Officer
7th Jun 20217:00 amRNSCustomer Win
4th Jun 20217:00 amRNSTrading Update
20th May 20217:00 amRNSAppointment of Chief Financial Officer
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:35 pmRNSPrice Monitoring Extension
13th Apr 20217:00 amRNSCustomer Win
30th Mar 202112:15 pmRNSAdditional Listing and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.